Skip to main content
Premium Trial:

Request an Annual Quote

IQuity IsolateIBS-IBD

IQuity launched its IsolateIBS-IBD blood-based test for the identification of irritable bowel syndrom or inflammatory bowel disease. The Nashville, Tennessee-based company said the test can determine IBS and IBD earlier than is possible with other tests and has accuracy greater than 90 percent. It can determine whether a person's RNA profile indicates the presence of IBS or IBD, and within IBD it provides information to differentiate between Crohn's disease and ulcerative colitis. 

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.